Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Endometriosis Market from 2024 to 2033?

The endometriosis market size has grown rapidly, forecasted to rise from $1.27 billion in 2023 to $1.4 billion in 2024, reflecting a CAGR of 10.4%. This growth is attributed to delayed diagnosis, increased awareness, advances in laparoscopic surgery, hormonal therapies, and patient advocacy.

The endometriosis market is expected to grow strongly, reaching $2.01 billion by 2028 with a CAGR of 9.3%. Growth is supported by minimally invasive procedures, pharmaceutical innovations, genetic research, and the global expansion of women’s healthcare. Major trends include patient-centered care, precision medicine, virtual care, and fertility preservation.

Claim Your Free Sample of the Global Endometriosis Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13035&type=smp

The rising incidence of ovarian cancer is expected to drive growth in the endometriosis market. Ovarian cancer, linked to endometriosis, has a higher risk associated with certain cancer subtypes. The American Cancer Society estimated around 19,710 new ovarian cancer cases in the U.S. in 2023, while the Ovarian Cancer Research Alliance reported an increase in deaths from 12,810 in 2022 to 13,270 in 2023. This increase in ovarian cancer incidence fuels the endometriosis market.

1) By Type: Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, Other Types

2) By Treatment Type: Hormonal Therapy, Pain Management

3) By Drug: Oral Contraceptives, Progestins, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Gonadotropin Releasing Hormone (GnRH) Analogues, Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs), Other Drugs

4) By End-User: Hospitals, Homecare, Specialty Centers, Other End-Users

Leading companies in the endometriosis market are introducing groundbreaking drugs like Myfembree to address the unmet need for effective treatment options. In August 2022, Myovant Sciences and Pfizer received FDA approval for Myfembree, a once-daily pill for managing moderate to severe endometriosis pain in premenopausal women. This medication combines relugolix, estradiol, and norethindrone acetate, offering dual indications for women who prefer not to use hormone therapy or are unable to.

Order Now for Fast Delivery of Your Endometriosis Market Report!

https://www.thebusinessresearchcompany.com/report/endometriosis-global-market-report

North America was the largest region in the maritime digitization market in 2023. The regions covered in the maritime digitization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Endometriosis Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the endometriosis market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Endometriosis Market Include

1. Endometriosis Market Executive Summary

2. Endometriosis Market Segments

3. Endometriosis Market Size And Template Market Growth Rate

4. Key Endometriosis Market Trends

5. Major Endometriosis Market Drivers

……

25. Key Mergers And Acquisitions In The Endometriosis Market

26. Top Endometriosis Companies

27. Endometriosis Market Opportunities And Strategies

28. Endometriosis Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Female Fertility And Pregnancy Rapid Test Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/female-fertility-and-pregnancy-rapid-test-global-market-report

Fertility Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

Fertility Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-services-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: